Total Payments
$7,035
2024 Payments
$2,980
Companies
55
Transactions
216
Medicare Patients
1,299
Medicare Billing
$42,320
Payment Breakdown by Category
Food & Beverage$6,350 (90.3%)
Education$684.33 (9.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,350 | 209 | 90.3% |
| Education | $684.33 | 7 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $565.52 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $500.44 | 14 | $0 (2024) |
| Incyte Corporation | $446.06 | 9 | $0 (2024) |
| Gilead Sciences, Inc. | $425.32 | 5 | $0 (2024) |
| Janssen Biotech, Inc. | $420.30 | 11 | $0 (2024) |
| Daiichi Sankyo Inc. | $381.62 | 19 | $0 (2024) |
| Astellas Pharma US Inc | $375.45 | 6 | $0 (2024) |
| Lilly USA, LLC | $343.59 | 8 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $283.94 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $252.56 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,980 | 104 | Takeda Pharmaceuticals U.S.A., Inc. ($270.11) |
| 2023 | $1,997 | 61 | Janssen Biotech, Inc. ($280.41) |
| 2022 | $1,515 | 29 | ABBVIE INC. ($411.28) |
| 2021 | $543.46 | 22 | Incyte Corporation ($135.00) |
All Payment Transactions
216 individual payment records from CMS Open Payments — Page 2 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Education | In-kind items and services | $89.99 | General |
| Category: Oncology | ||||||
| 10/04/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Oncology | ||||||
| 09/27/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $120.27 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Oncology | ||||||
| 09/20/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $29.65 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $21.42 | General |
| Category: Hematology/Oncology | ||||||
| 09/20/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $1.54 | General |
| Category: Hematology/Oncology | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Genentech USA, Inc. | Phesgo (Biological) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: BioOncology | ||||||
| 09/17/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Oncology | ||||||
| 09/06/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $10.10 | General |
| Category: Oncology | ||||||
| 09/06/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $1.33 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $2.05 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $1.73 | General |
| Category: ONCOLOGY | ||||||
| 09/04/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $0.71 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/23/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $110.12 | General |
| Category: Oncology | ||||||
| 08/14/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $29.51 | General |
| Category: HEMATOLOGY | ||||||
| 08/09/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Iron Deficiency Anemia | ||||||
| 08/02/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $15.79 | General |
| Category: Hematology | ||||||
| 08/01/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 100 | 117 | $36,630 | $7,644 |
| 2021 | 2 | 57 | 60 | $21,780 | $3,401 |
| 2020 | 16 | 1,142 | 1,252 | $104,108 | $31,275 |
Total Patients
1,299
Total Services
1,429
Medicare Billing
$42,320
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 49 | $20,482 | $4,299 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 56 | $16,016 | $3,244 | 20.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 12 | $132.00 | $100.80 | 76.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 33 | 35 | $14,630 | $2,254 | 15.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 25 | $7,150 | $1,147 | 16.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 145 | 160 | $44,032 | $12,095 | 27.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 191 | 211 | $35,086 | $10,694 | 30.5% |
| 51702 | Insertion of indwelling bladder catheter | Office | 2020 | 25 | 31 | $4,247 | $1,360 | 32.0% |
| 87086 | Bacterial colony count, urine | Office | 2020 | 131 | 145 | $2,900 | $1,155 | 39.8% |
| 84153 | Psa (prostate specific antigen) measurement | Office | 2020 | 53 | 54 | $2,430 | $978.63 | 40.3% |
| 87077 | Bacterial culture for aerobic isolates | Office | 2020 | 91 | 105 | $2,100 | $838.64 | 39.9% |
| 87184 | Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) | Office | 2020 | 91 | 105 | $1,785 | $776.25 | 43.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 22 | 23 | $2,300 | $738.36 | 32.1% |
| 84403 | Testosterone (hormone) level | Office | 2020 | 23 | 24 | $1,536 | $611.64 | 39.8% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 56 | 60 | $3,540 | $513.18 | 14.5% |
| 80048 | Blood test, basic group of blood chemicals | Office | 2020 | 59 | 60 | $1,260 | $499.61 | 39.7% |
| 81003 | Automated urinalysis test | Office | 2020 | 167 | 182 | $1,092 | $404.25 | 37.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 28 | 29 | $551.00 | $222.13 | 40.3% |
| 80076 | Liver function blood test panel | Office | 2020 | 20 | 20 | $400.00 | $161.16 | 40.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 14 | $614.66 | $141.06 | 22.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 29 | 29 | $234.35 | $85.86 | 36.6% |
About Berhane Mebratu, NP
Berhane Mebratu, NP is a Urology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/25/2018. The National Provider Identifier (NPI) number assigned to this provider is 1043718927.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Berhane Mebratu, NP has received a total of $7,035 in payments from pharmaceutical and medical device companies, with $2,980 received in 2024. These payments were reported across 216 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($6,350).
As a Medicare-enrolled provider, Mebratu has provided services to 1,299 Medicare beneficiaries, totaling 1,429 services with total Medicare billing of $42,320. Data is available for 3 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Nurse Practitioner, Nurse Practitioner
- Location Portland, OR
- Active Since 01/25/2018
- Last Updated 11/27/2024
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1043718927
Products in Payments
- MONJUVI (Drug) $409.58
- INJECTAFER (Drug) $294.17
- REBLOZYL (Biological) $253.52
- Epclusa (Drug) $250.00
- ENHERTU (Biological) $229.84
- SKYRIZI (Biological) $228.83
- LIBTAYO (Biological) $202.22
- BRUKINSA (Drug) $195.08
- XIFAXAN (Drug) $183.96
- OCALIVA (Drug) $162.20
- TECVAYLI (Biological) $152.84
- OPDIVO (Biological) $132.35
- ERLEADA (Drug) $125.00
- IMFINZI (Biological) $125.00
- Xospata (Drug) $125.00
- DOPTELET (Drug) $124.33
- ICLUSIG (Drug) $122.84
- Vemlidy (Drug) $121.84
- LUMAKRAS (Drug) $119.87
- MAVYRET (Drug) $119.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Portland
Dr. Lance Marr, M.d, M.D
Urology — Payments: $277,964
Urology $277,964
Dr. Geolani Dy, M.d, M.D
Urology — Payments: $69,493
Urology $69,493
Jyoti Chouhan, Do, Pharmd, DO, PHARMD
Urology — Payments: $62,636
Urology $62,636
David Sobel, Md, MD
Urology — Payments: $41,221
Urology $41,221
Dr. James Tycast, M.d, M.D
Urology — Payments: $38,374
Urology $38,374
Amir Patel
Urology — Payments: $35,329
Urology $35,329